Literature DB >> 1880122

Interaction of melittin and phospholipase A2 with azobenzene-containing phospholipid.

T Nishiya1.   

Abstract

Interactions of melittin and/or phospholipase A2 (PLA2) with circular dichroism (CD)-active phospholipid, bis(4'-n-octanoxyazobenzene-4-carboxyl)-L-alpha-phosphatidylcholin e (CDPC), were studied. In the presence of melittin at a lipid-to-melittin molar ratio (Ri) of 5, multilamellar dispersion, composed of CDPC and dipalmitoylphosphatidylcholine with a molar ratio of 1, underwent morphological change to form small melittin-lipid particles. When PLA2 was added to the melittin-lipid particles at 37 degrees C, the CD band at 222 nm exhibited a remarkable enhancement depending on Ri, indicating the formation of melittin-PLA2-lipid complex. After a 30 min incubation of melittin-PLA2-lipid complex at 45 degrees C in the presence of Ca2+, the CD band at 222 nm was still enhanced and a new positive band at 356 nm was observed. On the other hand, in the absence of Ca2+, the CD enhancement characteristic of melittin-PLA2-lipid complex disappeared after the incubation at 45 degrees C. These results suggest that the melittin-PLA2-lipid complex did not undergo any drastic morphological change upon PLA2-catalyzed hydrolysis of lipid, and that Ca2+ is indispensable in order that the melittin-PLA2-lipid complex remains intact and PLA2 exerts efficient hydrolytic activity in the melittin-PLA2-lipid complex.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1880122     DOI: 10.1093/oxfordjournals.jbchem.a123390

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  2 in total

Review 1.  Melittin, the Major Pain-Producing Substance of Bee Venom.

Authors:  Jun Chen; Su-Min Guan; Wei Sun; Han Fu
Journal:  Neurosci Bull       Date:  2016-03-17       Impact factor: 5.203

Review 2.  The nociceptive and anti-nociceptive effects of bee venom injection and therapy: a double-edged sword.

Authors:  Jun Chen; William R Lariviere
Journal:  Prog Neurobiol       Date:  2010-06-15       Impact factor: 11.685

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.